Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AlphaGroup Medical Communications was a private medical communications and scientific services company serving pharmaceutical, biotech, and medical device or diagnostic clients. The company specialized in scientific medical communications, medical affairs communications, strategic publication planning, and outcomes-related services including HEOR, real-world evidence, and payer communications. Founded in 2005 and based in King of Prussia, Pennsylvania, AlphaGroup supported products across the lifecycle from pre-clinical development through FDA approval, launch, and post-marketing activities. In December 2022, the company was acquired by Red Nucleus and is generally treated as a closed standalone entity within the acquirer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AlphaGroup Medical Communications.